bearish
Closing RAIN
SUMMARY
- Rain Oncology (RAIN) is being bought out for $1.16 + CVR worth up to $0.17/share.
- This seems like a worse deal than the $1.25 + CVR Tang was offering, but ok, I will take it.
- Usually these CVR’s should be valued at a large discount to their upper value, so I see no reason to hang around in this one so closing this one for a 15% gain at $1.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
x